"Die Kliniken Maria Hilf GmbH ist mit insgesamt 17 Fachabteilungen und über 2400 Mitarbeitern einer der größten Arbeitgeber in Mönchengladbach und eines der größten Ausbildungskrankenhäuser für Medizinstudenten der Universität Aachen. Die Kliniken Maria Hilf GmbH hat den Auftrag der Regel- und Schwerpunktversorgung, besitzt aber in vielen Bereichen den Anspruch der Maximalversorgung. Die Dichte an modernster Medizintechnik ist ein Garant für die hoch qualifizierte medizinische Versorgung der rund 36.000 stationären Fälle und mehr als 120.000 ambulanten Besuche pro Jahr. Rund 2.400 Mitarbeiter stehen für die 766 Betten zur Verfügung."

During the past decade, Kliniken Maria Hilf GmbH, Innere Medizin II, Klinik für Kardiologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kliniken Maria Hilf GmbH, Innere Medizin II, Klinik für Kardiologie" #1 collaborator was "Charite University, Berlin, Germany" with 1 trials as a collaborator and "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Kliniken Maria Hilf GmbH, Innere Medizin II, Klinik für Kardiologie" are "Heart Failure" (1 trials), "Iron Deficiency" (1 trials) and "Systolic Heart Failure" (1 trials). Many other conditions were trialed in "Kliniken Maria Hilf GmbH, Innere Medizin II, Klinik für Kardiologie" in a lesser frequency.

Most popular intervention types in "Kliniken Maria Hilf GmbH, Innere Medizin II, Klinik für Kardiologie" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Intracardiac Impedance Measurement Algorithm (integrated in CRT-D device)" (1 trials), "Iron" (1 trials) and "Saline" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kliniken Maria Hilf GmbH, Innere Medizin II, Klinik für Kardiologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kliniken Maria Hilf GmbH, Innere Medizin II, Klinik für Kardiologie". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Kliniken Maria Hilf GmbH, Innere Medizin II, Klinik für Kardiologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kliniken Maria Hilf GmbH, Innere Medizin II, Klinik für Kardiologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".